Boston Therapeutics Ipoxyn(TM) Data to be Presented Today at Symposium at Massachusetts General Hospital

MANCHESTER, N.H.--(BUSINESS WIRE)--Boston Therapeutics, Inc. (BTI), a public company registered with the SEC and a developer of diabetes therapeutics, announced today that experiments.
MORE ON THIS TOPIC